Abstract
Disrupted-In-Schizophrenia 1 (DISC1) was identified as a novel gene disrupted by a (1;11)(q42.1;q14.3) translocation that segregated with schizophrenia in a Scottish family. Predicted DISC1 product has no significant homology to other known proteins. Here, we demonstrated the existence of DISC1 protein and identified fasciculation and elongation protein zeta-1 (FEZ1) as an interacting partner of DISC1 by a yeast two-hybrid study. FEZ1 and its nematode homolog are reported to represent a new protein family involved in axonal outgrowth and fasciculation. In cultured hippocampal neurons, DISC1 and FEZ1 colocalized in growth cones. Interactions of these proteins were associated with F-actin. In the course of neuronal differentiation of PC12 cells, upregulation of DISC1/FEZ1 interaction was observed as along with enhanced extension of neurites by overexpression of DISC1. The present study shows that DISC1 participates in neurite outgrowth through its interaction with FEZ1. Recent studies have provided reliable evidence that schizophrenia is a neurodevelopmental disorder. As there is a high level of DISC1 expression in developing rat brain, dysfunction of DISC1 may confer susceptibility to psychiatric illnesses through abnormal development of the nervous system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McGuffin P, Owen MJ, Farmer AE . Genetic basis of schizophrenia. Lancet 1995; 346: 678–682.
Riley B, Williamson R . Sane genetics for schizophrenia. Nat Med 2000; 6: 253–255.
Sawa A, Snyder SH . Schizophrenia: diverse approaches to a complex disease. Science 2002; 296: 692–695.
Karayiorgou M, Gogos JA . A turning point in schizophrenia genetics. Neuron 1997; 19: 967–979.
Riley BP, McGuffin P . Linkage and associated studies of schizophrenia. Am J Med Genet 2000; 97: 23–44.
Berrettini WH . Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000; 48: 531–538.
Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS . Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21–q22. Science 2000; 288: 678–682.
Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity. Nature Genet 1995; 11: 287–293.
Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G et al. Schzophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998; 20: 70–73.
Williams J, Spurlock G, McGuffin P, Mallet J, Nothen MM, Gill M et al. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet 1996; 347: 1294–1296.
Sklar P, Schwab SG, Williams NM, Daly M, Schaffner S, Maier W et al. Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nat Genet 2001; 28: 126–128.
Anney RJ, Rees MI, Bryan E, Spurlock G, Williams N, Norton N et al. Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 2002; 7: 493–502.
Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CAM et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415–1423.
Blackwood DHR, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ . Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69: 428–433.
Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, Martin R et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 2001; 10: 1611–1617.
Katayama T, Imaizumi K, Tsuda M, Mori Y, Takagi T, Tohyama M . Expressions of an ADP-ribosylation factor like gene, ARF4L, is induced after transient forebrain ischemia in the gerbil. Brain Res Mol Brain Res 1998; 56: 66–75.
Neumann H, Cavalie A, Jenne DE, Wekerle H . Induction of MHC class I genes in neurons. Science 1995; 28: 549–552.
Smith L, Parizi-Robinson M, Zhu MS, Zhi G, Fukui R, Kamm KE et al. Properties of long myosin light chain kinase binding to F-actin in vitro and in vivo. J Biol Chem 2002; 277: 35597–35604.
Lehtonen S, Zhao F, Lehtonen E . CD2-associated protein directly interacts with the actin cytoskeleton. Am J Physiol Renal Physiol 2002; 283: F734–F743.
Fox JE . Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib. J Clin Invest 1985; 76: 1673–1683.
Bloom L, Horvitz HR . The Caenorhabditis elegans gene unc-76 and its human homologs define a new gene family involved in axonal outgrowth and fasciculation. Proc Natl Acad Sci USA 1997; 94: 3414–3419.
Kuroda S, Nakagawa N, Tokunaga C, Tatematsu K, Tanizawa K . Mammalian homologue of the Caenorhabditis elegans UNC-76 protein involved in axonal outgrowth is a protein kinase C ζ-interacting protein. J Cell Biol 1999; 144: 403–411.
Hall A . Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509–514.
Luo L . Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000; 1: 173–180.
Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 2003; 100: 289–294.
Weinberger DR . Implication of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660–669.
Lewis DA, Levitt P . Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002; 25: 409–432.
Harrison PJ . The neuropathology of schizophrenia.A critical review of the data and their interpretation. Brain 1999; 122: 593–624.
Heckers S, Konradi C . Hippocampal neurons in schizophrenia. J Neural Transm 2002; 109: 891–905.
Harrison PJ, Eastwood SL . Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001; 11: 508–519.
Millar JK, James R, Christie S, Taylor MS, Devon RS, Hogg G et al. Abstract from Xth World Congress on Psychiatric Genetics, 2002.
Kandpal G, Ma L, Acton P, Austin CP, Morris JA . Abstract from Society for Neuroscience 32nd Annual Meeting, 2002.
Acknowledgements
We acknowledge Drs A Sawa (Johns Hopkins University), N Mori and N Takei (Hamamatsu University School of Medicine), K Tanizawa and J Takeda (Osaka University) for critical reading of the manuscript and for valuable discussions and encouragement.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyoshi, K., Honda, A., Baba, K. et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 8, 685–694 (2003). https://doi.org/10.1038/sj.mp.4001352
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001352
Keywords
This article is cited by
-
Modeling disrupted synapse formation in wolfram syndrome using hESCs-derived neural cells and cerebral organoids identifies Riluzole as a therapeutic molecule
Molecular Psychiatry (2023)
-
Pathological oligodendrocyte precursor cells revealed in human schizophrenic brains and trigger schizophrenia-like behaviors and synaptic defects in genetic animal model
Molecular Psychiatry (2022)
-
Schizophrenia risk ZNF804A interacts with its associated proteins to modulate dendritic morphology and synaptic development
Molecular Brain (2021)
-
Sex-specific deficits in neurite density and white matter integrity are associated with targeted disruption of exon 2 of the Disc1 gene in the rat
Translational Psychiatry (2019)
-
The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions
Journal of Biomedical Science (2018)